Granules India arm gets USFDA nod for ADHD drug Lisdexamfetamine Dimesylate Ruchika Sharma30 Jan 2025 2:30 PM ISTHyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, has announced that its wholly-owned foreign...
USFDA nod to Granules India arm for ADHD treatment Ruchika Sharma17 Dec 2024 1:30 PM ISTHyderabad: Granules India Limited, a vertically integrated Indian pharmaceutical company, announced today that its wholly-owned foreign...
Granules India bags USFDA okay for Glycopyrrolate Oral Solution Ruchika Sharma20 Aug 2024 3:39 PM ISTHyderabad: Granules India has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA)...
Granules India arm gets USFDA nod for Gout flares drug Colchicine Ruchika Sharma30 April 2024 11:30 AM ISTColchicine Capsules are indicated for prophylaxis of gout flares in adults.
USFDA classifies Granules Pharma facility as Voluntary Action Indicated Ruchika Sharma4 April 2024 3:00 PM ISTHyderabad: Granules India has informed in a BSE filing that the United States Food and Drug Administration (USFDA) has classified the facility of...
Granules Pharma facility gets 5 USFDA observations Ruchika Sharma16 Dec 2023 12:14 PM ISTHyderabad: Granules India Limited has announced that the United States Food and Drug Administration (USFDA) has concluded a GMP inspection...
Granules India subsidiary bags USFDA nod for Sildenafil for Oral Suspension Ruchika Sharma4 Dec 2023 1:30 PM ISTSildenafil for Oral Suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in...
Granules Pharma successfully completes USFDA inspection with zero observations Ruchika Sharma4 Aug 2023 11:45 AM ISTHyderabad: Granules India Limited, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, located in...
Granules India arm bags USFDA nod for Acetaminophen and Ibuprofen Tablets Ruchika Sharma14 July 2023 11:09 AM ISTAcetaminophen and Ibuprofen Tablets are used for temporary relief for minor aches and pains due to: headache, toothache, backache, menstrual cramps,...
Granules Pharma bags USFDA nod for ADHD drug Amphetamine Mixed Salts ER Ruchika Sharma24 Jan 2023 12:02 PM ISTMixed Salts of a Single-Entity Amphetamine ER Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
USFDA okays Granules Pharma Bupropion Hydrochloride ER Tablets Ruchika Sharma4 Feb 2022 12:43 PM ISTHyderabad: Granules India Limited has recently announced that the US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug...
Granules India arm gets 3 USFDA observations for Chantilly facility Ruchika Sharma31 Jan 2022 1:02 PM ISTHyderabad: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in...
